Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
This historical analysis reveals the medical community’s involvement in advocating eugenic practices, emphasizing the need for modern physicians to understand and confront the lasting impact of these ideologies on healthcare and society.
All Specialties March 11th 2024
Psychiatrist.com
This study emphasizes the potential of MSK1 methylation levels and executive function as key indicators in predicting suicidal ideation among adolescents with major depressive disorder, providing a new dimension to our understanding of suicide risk factors in this age group.
Pediatrics March 5th 2024
Behçet’s syndrome presents a unique challenge in diagnosis and management, requiring a keen understanding of its diverse manifestations and the latest advances in treatment. Studies reveal a significant genetic component, with HLA-B*51 associations, underscoring the need for personalized treatment approaches.
Allergy & Immunology February 22nd 2024
Johns Hopkins Medicine
In an exciting development for schizophrenia research, Dr. Pan Li’s team utilizes CRISPR/Cas9 to explore neuron cell development, focusing on rare gene variants.
Neurology February 6th 2024
Parkinson’s News Today
In a landmark effort, seven molecules targeting the genetic roots of familial Parkinson’s disease were identified, showcasing the power of AI and open science in advancing treatment options. This collaborative achievement offers new avenues for understanding and potentially treating this challenging neurological disorder.
Neurology January 30th 2024
MDLinx
Recent findings from UC Davis highlight the role of executive function challenges as early indicators in men with FMR1 premutations for developing fragile X-associated tremor/ataxia syndrome (FXTAS), presenting a new avenue for timely intervention.
Neurology January 23rd 2024